Atlas Trials

An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment

Clinical trial NCT01254331 · COMPLETED

Trial details

NCT number
NCT01254331
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2011-02-01
Primary completion
2013-02-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.